Home  /  Resource Library  /  Brentuximab Vedotin in First Refractory/Relapsed Classical Hodgkin Lymphoma Patients Treated By Chemotherapy (ICE) before Autologous Transplantation

Brentuximab Vedotin in First Refractory/Relapsed Classical Hodgkin Lymphoma Patients Treated By Chemotherapy (ICE) before Autologous Transplantation

ASH 2019: Results of a phase II study examining brentuximab vedotin in combination with chemotherapy for treatment of relapsed Hodgkin lymphoma.